§ Federal grant opportunity · HT942526SCIRPTRA
DoW Spinal Cord Injury, Translational Research Award
Defense Health Agency Contracting Activity - DHACA is accepting applications for DoW Spinal Cord Injury, Translational Research Award. The deadline is November 12, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Defense Health Agency Contracting Activity - DHACA
- Application deadline
- November 12, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526SCIRPTRA
Program overview
Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Translational Research Award (TRA) supports translational research that will accelerate the movement of promising ideas in spinal cord injury (SCI) research into clinical applications. Distinctive Features: • This funding opportunity contains an Early-Career Partnership Option, which allows for two principal investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate award to the recipient organization(s). Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn. • Applications to this funding opportunity must name at least one SCI community partner (e.g., SCI Lived-Experience Consultant, representative of community-based organizations) who will provide advice and consultation throughout the planning and implementation of the research project.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Defense Health Agency Contracting Activity - DHACA.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before November 12, 2026, allowing time for registration and validation.
Related grant opportunities
- NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
- Advanced Technologies and Instrumentation for the Astronomical Sciences
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.